First, here is today's useful news.

"The Korean-style Mounjaro starts today."

Domestic obesity treatments will be sequentially prescribed at hospitals and clinics starting today.

They are known to be priced at about half the level of existing obesity treatments.

The newly launched obesity treatment is a GLP-1 receptor agonist injection administered once a week.

The supply price for the first four-week supply is 129,800 won, which is about half the starting dosage level of Mounjaro.

The actual cost borne by patients may vary depending on the medical institution.

Following its approval by the Ministry of Food and Drug Safety on October 7, prescriptions are being rolled out sequentially starting today.

With the launch of the domestic obesity treatment, market price competition is expected to intensify further.